Table 1.

Correlations between ENO1 expression and clinicopathological parameters in patients with HCC.

Clinicopathological parameter	Variables	ENO1 expression		Total	χ2	P valueb
		Low	High
Age (year)					1.138a	0.286
	≤57	20	27	47
	>57	15	32	47
Sex					0.044	0.833
	male	31	50	81
	female	4	9	13
TNM stage					4.932a	0.026
	I/II	27	32	59
	III/IV	8	27	35
Grade					5.894a	0.015
	I/II	27	32	59
	III	7	27	34
		1		1
Tumor thrombus					2.956a	0.086
	−	24	35	59
	+	5	19	24
		6	5	11
Cirrhosis					1.098a	0.295
	−	5	15	20
	+	26	43	69
		4	1	5
HBsAg					0.013	0.908
	−	3	7	10
	+	30	50	80
		2	2	4
HBcAb						0.527
	−	0	2	2
	+	29	47	76
		6	10	16
TB					0.204a	0.652
	≤17.1	20	37	57
	>17.1	12	18	30
		3	4	7
ALT					0.618a	0.432
	≤40	15	30	45
	>40	19	27	46
		1	2	3
ALB					0.265a	0.607
	≤40	12	24	36
	>40	19	30	49
		4	5	9
AFP					1.165a	0.28
	≤30	12	16	28
	>30	17	38	55
		6	5	11
Hepatitis					0.118	0.731
	−	1	4	5
	+	34	55	89
CD34						0.526
	-	0	2	2
	+	23	37	60
		12	20	32
CK19					0.144a	0.704
	−	23	41	64
	+	12	18	30
Recurrence or
metastasis						0.725
	−	13	15	28
	+	4	7	11
		18	37	55

^a0 cells (0.0%) have expected count less than 5. ^bP value was calculated by χ² test of Fisher’s exact test.

The bold number represents the p-values with significant differences.